about
Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Should patients with locally advanced, non-metastatic carcinoma of the pancreas be irradiated?On the performances of different IMRT Treatment Planning Systems for selected paediatric casesPreoperative thrombocytosis predicts poor survival in patients with glioblastoma.Overall survival after reirradiation of spinal metastases - independent validation of predictive models.Fully automated treatment planning of spinal metastases - A comparison to manual planning of Volumetric Modulated Arc Therapy for conventionally fractionated irradiationIntensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs: issues and how to detect them.Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancerA fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT)kV cone-beam CT-based IGRT: a clinical review.A novel surface imaging system for patient positioning and surveillance during radiotherapy. A phantom study and clinical evaluation.Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?Review of potential improvements using MRI in the radiotherapy workflow.A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review.A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.The future of MRI in radiation therapy belongs to integrated MRI-linac systems, not the standalone MRI-Sim.SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment.A machine learning tool for re-planning and adaptive RT: A multicenter cohort investigation.MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.Flattening filter free beams from TrueBeam and Versa HD units: Evaluation of the parameters for quality assurance.Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide.No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.Cardiac Function After Multimodal Breast Cancer Therapy Assessed With Functional Magnetic Resonance Imaging and Echocardiography Imaging.Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicityDevelopment of a neuro-fuzzy technique for automated parameter optimization of inverse treatment planning.Intensity modulated radiosurgery of brain metastases with flattening filter-free beams.Accelerating total body irradiation with large field modulated arc therapy in standard treatment rooms without additional equipment.Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer.Expert system classifier for adaptive radiation therapy in prostate cancer.Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy.Flattening-filter-free intensity modulated breath-hold image-guided SABR (Stereotactic ABlative Radiotherapy) can be applied in a 15-min treatment slot.Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer.
P50
Q26823670-F91261A9-4924-4752-8CCD-713A2AFC2A43Q30570350-DC562971-B762-41DF-AA6A-C76BDDC061F3Q30872867-D33B45F7-1AF8-40F1-9700-14326A589D63Q34471442-5A4A6C6A-2657-4F72-A4C6-B33C9F1FF7E5Q34479911-859B3B2B-08B4-4A1B-85EA-839D0C2958CBQ35550038-227C3155-5DFF-42BF-99C5-AA4B1A0AEFC3Q35648644-B89E8EF1-C3CF-41AE-9334-9BB6B2F0A53AQ35870489-211433CC-5D21-479E-A80E-B0884B2B5C02Q35948182-087516B5-CE0B-4E96-9713-5AD9E75F8A60Q36265853-6430D6D2-2FF3-4BCE-B2FD-2D1FD2EE397FQ36560285-AE55B567-E822-455B-B3E9-F1F309753824Q36765574-48729E75-3978-403F-906B-2F9DC199AC85Q37415461-E5D2ABEF-7A45-4690-A9E3-E2FDEC70EC82Q37870806-FA3B1586-5209-42E0-9D3C-8CB7D6EBF7D9Q38143597-A62A2013-0260-44FE-85BC-EB696EE7B72FQ38248237-3FC58AD0-B799-4B07-8A41-BC5A63E32FDAQ38380957-5DFA0100-5C62-4F63-9485-6C4FEE019E0BQ38724864-62893EF0-7A1E-40B0-BD3A-FF6F68FF0D6AQ38729905-86D7451E-79C3-434E-B9BB-F4B542E81EC2Q38762723-43818932-9828-4889-80A3-48542B78C545Q38773617-63A7161D-552B-4906-ADB2-CF43FC79F6BDQ38846129-3E08FCE6-82F9-41F3-B1EA-53A215388678Q39265538-21144C42-FFF3-4215-9B1B-DA6A4D5B5638Q39619832-930A4C8C-35D6-4B8F-A7CC-73845A8BEA5EQ40128483-31E083EC-AF5A-4B01-B993-EF44C8969178Q40130165-1BAF4F3F-A55F-4A18-88EF-01253084DA02Q40224759-C9122061-31CA-4955-A356-56C5082A61E1Q40360090-494B4DFC-5DFF-4319-ABE7-6B34D533A52AQ40476063-ED02D56F-D335-45FD-A7B8-1C9904C80053Q41153429-CDBC0203-311E-4BBF-A2B1-2E7E83BB83B1Q41962815-F0A06258-8E77-4CE4-AF8D-F89890AA1EF1Q42001401-09EECE68-E1E4-4893-879E-AC079E1E67D4Q43606721-C4E75F3D-13A8-413E-AA7E-D2D575CEA0D9Q43794328-937DA5F9-118D-4400-BED4-983487BF5E4EQ44839037-75FB4C25-EFBC-4020-B182-0EA8D9C0C5B9Q45948106-50F9EDBB-FB41-41FE-A74D-FD267BDC89D8Q46028353-F29666C3-1700-475C-ACB1-318E60617779Q46092458-41AE24BC-A5DA-49D0-9D42-D0CE3BB9F772Q46215321-3BD5CA82-1E13-438D-B94F-F65F842DC235Q46497267-EC3D4E9E-7ACC-41D4-A9A0-16084350730D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
F Lohr
@ast
F Lohr
@en
F Lohr
@es
F Lohr
@nl
type
label
F Lohr
@ast
F Lohr
@en
F Lohr
@es
F Lohr
@nl
prefLabel
F Lohr
@ast
F Lohr
@en
F Lohr
@es
F Lohr
@nl
P106
P1153
35292636000
P31
P496
0000-0003-1014-5556